Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
19m agoGray Media and Byron Allen’s Allen Media Group Closed Station Transactions
52m agoUraniumx Reports Strong Financial Position Ahead of Spring Drill Program
1h agoBillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics
1h agoTarget Offers 10% Teacher Discount Nationwide During Teacher Appreciation Week, Alongside Year-Round Benefits
2h agoPennant Acquires Senior Living Communities in Arizona and Wisconsin
Pharma Mar S.a. logo

Pharma Mar S.a.

About

Pharma Mar S.a. (MC:PHM) — investor relations, events, news, and company updates on 6ix.

Latest News

Jun 3 2025
PharmaMar presents at ASCO that the Zepzelca®(lurbinectedin) and atezolizumab (Tecentriq®) combination significantly improves survival as first-line maintenance therapy for extensive-stage small cell lung cancer

Community Chat

Ask AI

6ix6ix